AU2517199A - Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent - Google Patents

Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent

Info

Publication number
AU2517199A
AU2517199A AU25171/99A AU2517199A AU2517199A AU 2517199 A AU2517199 A AU 2517199A AU 25171/99 A AU25171/99 A AU 25171/99A AU 2517199 A AU2517199 A AU 2517199A AU 2517199 A AU2517199 A AU 2517199A
Authority
AU
Australia
Prior art keywords
whichcontains
acarbose
medicament
mouth
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25171/99A
Inventor
Johanna Berberich
Carola Portner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2517199A publication Critical patent/AU2517199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU25171/99A 1998-01-24 1999-01-12 Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent Abandoned AU2517199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19802700 1998-01-24
DE1998102700 DE19802700A1 (en) 1998-01-24 1998-01-24 Preparation of fast-dissolving tablets for controlling blood sugar levels
PCT/EP1999/000131 WO1999037308A1 (en) 1998-01-24 1999-01-12 Method for producing a medicament which quickly dissolves in the mouth and which contains acarbose as an active agent

Publications (1)

Publication Number Publication Date
AU2517199A true AU2517199A (en) 1999-08-09

Family

ID=7855589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25171/99A Abandoned AU2517199A (en) 1998-01-24 1999-01-12 Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent

Country Status (3)

Country Link
AU (1) AU2517199A (en)
DE (1) DE19802700A1 (en)
WO (1) WO1999037308A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2367900A (en) * 1998-12-18 2000-07-03 Bayer Corporation Chewable drug delivery system
DE10207394B4 (en) 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Taste-masked oblate medicinal preparation
JP2011506279A (en) * 2007-12-08 2011-03-03 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト Orally dispersible tablets
KR101421330B1 (en) * 2008-12-17 2014-07-18 사토 세이야쿠 가부시키가이샤 A disintegrating tablet
TWI556823B (en) * 2010-04-27 2016-11-11 拜耳智慧財產有限公司 Orally disintegrating tablet containing acarbose
TR201100150A2 (en) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Water soluble dosage forms
WO2013115745A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin)
CN104013590A (en) * 2014-05-09 2014-09-03 万特制药(海南)有限公司 Acarbose-containing medicinal composition and preparation method thereof
WO2016097170A1 (en) * 2014-12-17 2016-06-23 Empros Pharma Ab A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
CN109803931A (en) * 2016-10-05 2019-05-24 博爱新开源医疗科技集团股份有限公司 Tablet composition containing crosslinked polyvinylpyrrolidone and its purposes in beverage application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3543999A1 (en) * 1985-12-13 1987-06-19 Bayer Ag HIGH PURITY ACARBOSE
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor

Also Published As

Publication number Publication date
WO1999037308A1 (en) 1999-07-29
DE19802700A1 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
HUP0100848A3 (en) Aerosolized active agent delivery
AU5732699A (en) Corneal onlay
AU1513400A (en) A foaming tablet for cleaning the oral cavity and preparation method thereof
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2517199A (en) Method for producing a medicament which quickly dissolves in the mouth and whichcontains acarbose as an active agent
HU9801025D0 (en) Process for producing pharmaceutical active agent
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU6442900A (en) Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
AU5965399A (en) Pharmaceutically active composition
AU1554301A (en) Radioprotecting agent
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same
AU687948B2 (en) Antiallergy agent and process for the production thereof
AU7268800A (en) Active agent preparation for veterinary use and method for the production thereof
HUP0004386A3 (en) Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
AU5696400A (en) Improved software interface agent
AU2002218494A1 (en) Medicinal compositions and process for producing the same
EP1221863A4 (en) Chewing gum containing medicament active agents
AU5477100A (en) Caspase-8 crystals, models and methods
AU8888198A (en) Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same
HUP0103623A3 (en) Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
AU2002223645A1 (en) Method for producing readily soluble medicament formulations and corresponding formulations
AU2401401A (en) Migrastatin, process for producing the same and medicinal compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase